Bridging the gap: Extracellular matrix-based strategies for peripheral nerve regeneration and neuropathic pain management.

IF 7.7 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Siddharth Raj, Abhijeet R Joshi
{"title":"Bridging the gap: Extracellular matrix-based strategies for peripheral nerve regeneration and neuropathic pain management.","authors":"Siddharth Raj, Abhijeet R Joshi","doi":"10.1111/bph.70183","DOIUrl":null,"url":null,"abstract":"<p><p>Peripheral neuropathic pain, arising from peripheral nerve injuries, remains a significant clinical challenge because of complex pathophysiology and limited treatment options. Conventional treatments primarily provide symptomatic relief, failing to address underlying nerve damage. The extracellular matrix (ECM) plays a vital role in nerve regeneration by offering structural support and biochemical signals that regulate Schwann cell behaviour, axonal growth and microenvironment remodelling. This review critically examines ECM-based scaffold strategies, focussing on natural proteins such as collagen, laminin and fibronectin and their role in promoting functional nerve recovery. In addition, the role of emerging molecular regulators, including Piezo1 mechanosensitive channels and nuclear transport proteins, is examined for their ability to mediate mechanotransduction and gene regulatory mechanisms critical for nerve regeneration and pain modulation. By integrating biomaterial engineering, mechanical signalling pathways and gene-targeted strategies, this review outlines promising regenerative approaches aimed at restoring nerve function and alleviating chronic pain. These insights may guide the development of next-generation therapies for peripheral nerve repair.</p>","PeriodicalId":9262,"journal":{"name":"British Journal of Pharmacology","volume":" ","pages":""},"PeriodicalIF":7.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bph.70183","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Peripheral neuropathic pain, arising from peripheral nerve injuries, remains a significant clinical challenge because of complex pathophysiology and limited treatment options. Conventional treatments primarily provide symptomatic relief, failing to address underlying nerve damage. The extracellular matrix (ECM) plays a vital role in nerve regeneration by offering structural support and biochemical signals that regulate Schwann cell behaviour, axonal growth and microenvironment remodelling. This review critically examines ECM-based scaffold strategies, focussing on natural proteins such as collagen, laminin and fibronectin and their role in promoting functional nerve recovery. In addition, the role of emerging molecular regulators, including Piezo1 mechanosensitive channels and nuclear transport proteins, is examined for their ability to mediate mechanotransduction and gene regulatory mechanisms critical for nerve regeneration and pain modulation. By integrating biomaterial engineering, mechanical signalling pathways and gene-targeted strategies, this review outlines promising regenerative approaches aimed at restoring nerve function and alleviating chronic pain. These insights may guide the development of next-generation therapies for peripheral nerve repair.

弥合差距:细胞外基质为基础的策略周围神经再生和神经性疼痛管理。
周围神经损伤引起的周围神经性疼痛,由于其复杂的病理生理和有限的治疗选择,仍然是一个重大的临床挑战。传统治疗主要提供症状缓解,未能解决潜在的神经损伤。细胞外基质(extracellular matrix, ECM)通过提供结构支持和生化信号,调控雪旺细胞行为、轴突生长和微环境重塑,在神经再生中起着至关重要的作用。本文综述了基于ecm的支架策略,重点关注天然蛋白,如胶原蛋白、层粘连蛋白和纤维连接蛋白及其在促进神经功能恢复中的作用。此外,新兴分子调节剂的作用,包括Piezo1机械敏感通道和核转运蛋白,研究了它们介导机械转导和基因调节机制的能力,这些机制对神经再生和疼痛调节至关重要。通过整合生物材料工程、机械信号通路和基因靶向策略,本文概述了旨在恢复神经功能和减轻慢性疼痛的有前途的再生方法。这些见解可能指导下一代周围神经修复疗法的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.40
自引率
12.30%
发文量
270
审稿时长
2.0 months
期刊介绍: The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries. Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues. In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信